AGARWALEYEBSEDr. Agarwals Health Care LtdHighNegative
Announced Thu, 21 May · 21:07 IST

As per the letter enclosed.

Regulatory & Legal View source PDF

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹482.00
prior close
₹487.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.4+0.2+1.1-0.4-0.6-0.5+1.0-0.4-4.4-8.8-2.5-0.0
Up moveDown movePending
AI summary

The company received a Show Cause Notice (SCN) dated May 18, 2026 from the Assistant Commissioner, GST & Central Excise, Chennai. The SCN alleges discrepancies in GST returns and statements filed for FY 2023-24, including differences in output turnover, short payment of tax under RCM, excess/incorrect ITC claims, and non-compliance of E-invoicing. The authorities have demanded Rs. 20.50 Crores (including GST, interest, and penalty), with the company required to respond within 30 days. Management states the email was initially overlooked due to spam overload and is now examining the notice. The company claims no material financial or operational impact is expected.

Likely market impact

While the SCN carries a Rs. 20.50 crore demand, the company has not acknowledged liability and expects no material impact. However, unresolved GST disputes can escalate to penalties, enforcement action, or reputational risk for a listed entity.